Skip to main content
SpringerLink
Log in

Rational Therapy of Eating Disorders

  • Practical Therapeutics
  • Published:
Drugs Aims and scope Submit manuscript

Abstract

Pharmacological treatments are one of several strategies used in the treatment of anorexia nervosa and bulimia nervosa. Many studies have found that antidepressants are effective in the treatment of bulimia nervosa and these drugs represent a mainstay of treatment for these patients. Over the past several years, selective serotonin reuptake inhibitors have become perhaps the most commonly used class of drugs. A variety of medications have been investigated for anorexia nervosa, but there is little consistent evidence that medications are effective. In both these illnesses it is important to diagnose and treat any comorbid conditions including mood and anxiety disorders; this may involve the administration of other medications, including anxiolytics such as benzodiazepines or buspirone or mood stabilising agents such as lithium, valproic acid (valproate sodium) or carbamazepine.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Pyle RL, Mitchell JE, Eckert ED, et al. The incidence of bulimia in freshman college students. Int J Eat Disord 1983; 2: 75–85

    Article  Google Scholar 

  2. Hasan MK, Tibbetts RW. Primary Anorexia nervosa (weight phobia) in males. Postgrad Med J 1977; 53: 146–151

    Article  PubMed  CAS  Google Scholar 

  3. Crisp AH, Burns T. The clinical presentation of anorexia nervosa in males. Int J Eat Disord 1983; 2: 5–10

    Article  Google Scholar 

  4. Mitchell JE, Groat R. A placebo-controlled, double-blind trial of amitriptyline in bulimia. J Clin Psychopharmacol 1984; 4: 186–93

    Article  PubMed  CAS  Google Scholar 

  5. Home RL, Ferguson JM, Pope HG, et al. Treatment of bulimia with bupropion: a multicenter, controlled trial. J Clin Psychiatry 1988; 42: 262–6

    Google Scholar 

  6. Barlow J, Blouin J, Blouin A, et al. Treatment of bulimia with desipramine: a double blind, crossover study. Can J Psychiatry 1988; 33: 129–33

    PubMed  CAS  Google Scholar 

  7. Blouin AG, Blouin JH, Perez EL, et al. Treatment of bulimia with fenfluramine and desipramine. J Clin Psychopharmacol 1988; 8: 261–9

    Article  PubMed  CAS  Google Scholar 

  8. Hughes PL, Wells LA, Cunningham CJ, et al. Treating bulimia with desipramine. Arch Gen Psychiatry 1986; 43: 182–6

    Article  PubMed  CAS  Google Scholar 

  9. Walsh BT, Hadigan CM, Devlin MJ, et al. Long-term outcome of antidepressant treatment for bulimia nervosa. Am J Psychiatry 1991; 148: 1206–12

    PubMed  CAS  Google Scholar 

  10. Fichter MM, Leibl K, Rief W, et al. Fluoxetine versus placebo: a double blind study with bulimic inpatients undergoing intensive psychotherapy. Pharmacopsychiatry 1991; 24: 1–7

    Article  PubMed  CAS  Google Scholar 

  11. Fluoxetine Bulimia Nervosa Collaborative Study Group. Fluoxetine in the treatment of bulimia nervosa. Arch Gen Psychiatry 1992; 139-47

  12. Freeman CPL, Davies F, Morris J, et al. A double-blind, controlled trial of fluoxetine versus placebo for bulimia nervosa. Br J Psychiatry. In press

  13. Fichter M. Antidepressant therapy revisited for bulimia nervosa. 9th World Congress of Psychiatry; 1993 June: Rio de Janeiro, Brazil

  14. Agras WS, Dorian B, Kirkley BG, et al. Imipramine in the study of bulimia: a double-blind, controlled study. Int J Eating Disorders 1987; 6: 29–38

    Article  Google Scholar 

  15. Mitchell JE, Pyle RL, Eckert ED, et al. A comparison study of antidepressants and structured intensive group psychotherapy in the treatment of bulimia nervosa. Arch Gen Psychiatry 1990; 47: 149–57

    Article  PubMed  CAS  Google Scholar 

  16. Pope HG, Hudson JI, Jonas JM, et al. Bulimia treated with imipramine: a double-blind, placebo-controlled study. Am J Psychiatry 1983; 140: 554–8

    PubMed  Google Scholar 

  17. Sabine EJ, Yonace A, Farrington AJ, et al. Bulimia nervosa: a placebo-controlled double-blind therapeutic trial of mianserin. Br J Clin Pharmacol 1983; 15: S195–S202

    Article  Google Scholar 

  18. Walsh BT, Gladis M, Roose SP, et al. Phenelzine vs placebo in 50 patients with bulimia. Arch Gen Psychiatry 1988; 45: 471–5

    Article  PubMed  CAS  Google Scholar 

  19. Pope HG, Keck PE, McElroy SL, et al. A placebo-controlled study of trazodone in bulimia nervosa. J Clin Psychopharmacol 1989; 9: 254–9

    Article  PubMed  Google Scholar 

  20. Pope HG, Hudson JI, Jonas JM, et al. Antidepressant treatment of bulimia: a two year follow up study. J Clin Psychopharmacol 1985; 5: 320–7

    PubMed  Google Scholar 

  21. Russell GFM, Checkley SA, Feldman J, et al. A controlled trial of d-fenfluramine in bulimia nervosa. Clin Neuropharmacol 1988; 11: S146–59

    PubMed  Google Scholar 

  22. Hsu LKG, Clement L, Santhouse R, et al. Treatment of bulimia nervosa with lithium carbonate: a controlled study. J Nerv Ment is 1991; 179: 351–5

    Article  CAS  Google Scholar 

  23. Mitchell JE, Laine DE, Morley JE, et al. Naloxone but not CCK-8 may attenuate binge-eating behavior in patients with the bulimia syndrome. Biol Psychiatry 1986; 21: 1399–406

    Article  PubMed  CAS  Google Scholar 

  24. Igoin-Apfelbaum L, Apfelbaum M. Naltrexone and bulimic symptoms [letter]. Lancet 1987; 2: 1087–8

    Article  PubMed  CAS  Google Scholar 

  25. Mitchell JE, Christenson G, Jennings J, et al. A placebo-controlled, double-blind crossover study of naltrexone hydrochloride in outpatients with normal weight bulimia. J Clin Psychopharmacol 1989; 9: 94–7

    Article  PubMed  CAS  Google Scholar 

  26. Alger SA, Schwalberg MD, Bigaoutte JM, et al. Effects of a tricyclic antidepressant and opiate antagonists on binge-eating behavior in normoweight bulimic and obese, binge-eating subjects. Am J Clin Nutr 1991; 53: 865–71

    PubMed  CAS  Google Scholar 

  27. Wermuth BM, Davis KL, Hollister LE, et al. Phenytoin treatment of the binge eating syndrome. Am J Psychiatry 1977; 134: 1249–53

    PubMed  CAS  Google Scholar 

  28. Krahn D, Mitchell JE. Use of 1-tryptophan in treating bulimia [letter]. Am J Psychiatry 1985; 142: 1130

    PubMed  CAS  Google Scholar 

  29. Green RS, Rau JH. Treatment of compulsive eating disturbances with anticonvulsant medications. Am J Psychiatry 1974; 131: 428–32

    PubMed  CAS  Google Scholar 

  30. Biederman J, Herzog DB, Rivinus TM, et al. Amitriptyline in the treatment of anorexia nervosa: a double-blind, placebo-controlled study. J Clin Psychopharmacol 1985; 5 (1): 10–6

    Google Scholar 

  31. Halmi KA, Eckert E, LaDu TJ, et al. Anorexia nervosa: treatment efficacy of cyproheptadine and amitriptyline. Arch Gen Psychiatry 1986; 43 (2): 177–81

    Google Scholar 

  32. Stacher G, Abatzi-Wenzel TA, Wiesnagrotzki S, et al. Gastric emptying, body weight and symptoms in primary anorexia nervosa. Long-term effects of cisapride. Br J Psychiatry 1993; 162: 398–402

    CAS  Google Scholar 

  33. Lacey JH, Crisp AH. Hunger, food intake and weight: the impact of clomipramine on a refeeding anorexia nervosa population. Postgrad Med 1980; 56 Suppl.1: 79–85

    Google Scholar 

  34. Casper RC, Schlemmer Jr RF, Javaid JI. A placebo-controlled crossover study of oral Clonidine in acute anorexia nervosa. Psychiatry Res 1987; 20 (3): 249–60

    Google Scholar 

  35. Goldberg SC, Halmi KA, Eckert ED, et al. Anorexia nervosa: therapeutic efficacy or cyproterone and amitriptyline. Br J Psychiatry 1979; 134: 67–70

    Article  PubMed  CAS  Google Scholar 

  36. Vigersky RA, Loriaux DL. In: Vigersky RA, editor. Anorexia nervosa. New York: Raven Press, 1977: 346-56

  37. Gross HA, Ebert MH, Faden VB, et al. A double-blind controlled trial of lithium carbonate primary anorexia nervosa. J Clin Psychopharmacol 1981; 1 (6): 376–81

    Google Scholar 

  38. Vandereycken W, Pierloot R. Pimozide combined with behavior therapy in the short-term treatment of anorexia nervosa: a double-blind placebo-controlled cross-over study. Acta Psy-chiatr Scand 1982; 66 (6): 445–50

    Google Scholar 

  39. Vandereycken W. Neuroleptics in the short-term treatment of anorexia nervosa: a double-blind placebo-controlled study with sulpiride. Br J Psychiatry 1984; 144: 288–92

    Article  PubMed  CAS  Google Scholar 

  40. Gross HA, Ebert MH, Faden VB, et al. A double-blind trial of delta 9-tetrahydrocannabinol in primary anorexia nervosa. J Clin Psychopharmacol 1983; 3 (3): 165–71

    Google Scholar 

  41. Kaye WH, Weltzin TE, Shu LK, et al. An open trial of fluoxetine in patients with anorexia nervosa. J Clin Psychiatry 1991; 52 (11): 464–71

    Google Scholar 

  42. Gwirtsman HE, Guze BH, Yager J, et al. Fluoxetine treatment of anorexia nervosa: an open clinical trial. J Clin Psychiatry 1991; 52 (5): 240–1

    Google Scholar 

  43. Silverstone T, Schuyler D. The effect of cyproheptadine on hunger, calorie intake and body weight in man. Psychopharma-cology 1975; 40: 335–40

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Psychiatry, University of Minnesota, Box 393 UMHC, Minneapolis, Minnesota, MN 55455, USA

    James E. Mitchell

Authors
  1. Scott J. Crow
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. James E. Mitchell
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Crow, S.J., Mitchell, J.E. Rational Therapy of Eating Disorders. Drugs 48, 372–379 (1994). https://doi.org/10.2165/00003495-199448030-00004

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00003495-199448030-00004

Keywords

Search

Navigation